Individualizing Treatment for Urinary Incontinence - Evolving Research Questions into Research Plans
Although treatment options exist for people with urinary incontinence (UI), outcomes vary and there is insufficient information about the individual biologic and non-biologic factors that might affect treatment success, behaviors, and individual quality of life. With a variety of potential approaches, shared decision making is important to develop a treatment strategy that aligns with an individual’s preferences and goals of care and behaviors. All affected populations—female, male, children, neurogenic (congenital or acquired)—can benefit from individualized treatment approaches.
In March 2017, the National Institutes of Health (NIH) hosted Individualizing Treatment—Broadening the Framework for Urinary Incontinence Research, where participants reviewed numerous biologic and non-biologic factors that may influence individual treatment success and identified hypotheses and research questions to build the knowledge base that will enable better targeting of existing treatments to appropriate persons with UI. Read the March 2017 meeting summary (PDF, 501.12 KB)
Day 1: Thursday, Feb 1: 12:30pm – 5:30pm
Call-in toll number (US/Canada)
Access code: 625 660 532
Day 2: Friday, Feb 2: 9:00am – 11:00am
Call-in toll number (US/Canada)
Access code: 623 938 508
The goal of this meeting is to build on the ideas generated by the March 2017 meeting to develop fundable, interdisciplinary, investigator-initiated research proposals that will lead to better outcomes for currently available treatments by individualizing them to each patient, considering characteristics across the spectrum from biology to the social determinants of health. Adopting this broader framework for research will require engaging researchers from scientific fields beyond urology.
- Enhance interdisciplinary thinking among specialists and those with interest and involvement in UI research, including pelvic medicine and reconstructive surgeons, urologists, obstetrician-gynecologists, geriatricians, pediatricians, behavioral scientists, basic scientists, engineers, nurses, physical therapists, occupational therapists, administrators, and economists.
- Expand participant understanding of the role of basic science, engineering, behavioral science, and clinical science in individualizing treatment for persons with UI and how it affects their caregivers and community.
- Inform participants of novel research methodologies that can be used to study individualizing treatment and examine outcomes.
- Discuss opportunities to involve families, peers, and other social network members of people with UI into research, treatment, and ongoing care.
- Guide interdisciplinary research teams in the development of actionable research plans that will enable improved targeting of existing or novel UI treatments.
- Provide time for research teams to confer with experts in clinical trial methodology and biostatistics regarding their research strategy.
Optional Pre-meeting Workshop for New Investigators
On the morning of February 1, prior to the main scientific session, the NIDDK is hosting an optional session, Establishing a Research Career in Benign Urologic Conditions. This optional workshop will review federal funding sources for research on benign urologic conditions, discuss strategies for balancing clinical care and research, and provide mentoring opportunities from senior investigators, among other activities. Interested participants can register to attend the pre-meeting workshop during the main meeting registration process.
Bring Your Research Team
Participants are encouraged to invite and bring colleagues from their institutions with diverse areas of expertise to facilitate interdisciplinary research planning. Having attended the March 2017 meeting is not necessary for participants to engage in or benefit from the February 2018 meeting. Participants are encouraged to review the Executive Summary of the March 2017 meeting at the link above.
January 26, 2018
View the list of attendees (PDF, 27.28 KB) .
Natcher Conference Center
45 Center Drive, NIH Campus
Tamara Bavendam, M.D., M.S.
The Scientific Consulting Group, Inc.